FIRST EXTENSION - GRANTED
granted
on 11 Jun 2024
Last Applicant/ Owned by
Suite 6-401
Cambridge
MA
02139
Serial Number
97493218 filed on 07th Jul 2022
Registration Number
N/A
Correspondent Address
Tiffany D. Gehrke
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
KORRO BIO
Pharmaceutical preparations for the treatment of rare genetic diseases; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceutical preparations containing biomedical compounds comprised of ribonucleic acid polymers for the treatment Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of rare genetic diseases; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceutical preparations containing biomedical compounds comprised of ribonucleic acid polymers for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use in RNA editing; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use in base editing; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use as RNA therapeutic for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceuticals, namely, bio-pharmaceutical preparations for the treatment of rare diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacture of biomedical compounds comprised of nucleotide polymers or biomedical compounds comprised of ribonucleic acid polymers for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97493218
Mark Type
No Service Mark
Attorney Docket Number
No 33791/60000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Aug 2024 | CORRECTED NOA E-MAILED |
| 20th Aug 2024 | DIVISIONAL PROCESSING COMPLETE |
| 08th Aug 2024 | DIVISIONAL REQUEST RECEIVED |
| 02th Aug 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 13th Jun 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| 11th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 11th Jun 2024 | SOU EXTENSION 1 GRANTED |
| 11th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 11th Jun 2024 | SOU EXTENSION 1 FILED |
| 02th Jan 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |